DOT - 5 Panel Drug Testing
$85
A DOT drug test refers to a drug screening required by the U.S. Department of Transportation (DOT) for employees in safety-sensitive positions within the transportation industry. The primary aim is to ensure that these employees do not use illicit drugs or misuse prescription medications, which could impair their ability to perform their job safely and thereby jeopardize public safety.
Who is tested?
The DOT drug testing requirements apply to safety-sensitive employees, which include, but are not limited to:
Federal Motor Carrier Safety Administration (FMCSA)
Pipeline and Hazardous Materials Safety Administration (PHMSA)
Federal Aviation Administration (FAA)
Federal Railroad Administration (FRA)
Federal Transit Administration (FTA)
US Coast Guard (USCG)
The DOT drug test screens for the following substances:
Marijuana (THC)
Cocaine
Opiates (morphine, codeine, and heroin)
Amphetamines and methamphetamines
Phencyclidine (PCP)
DOT drug tests have stringent procedures in place for:
Collection of samples (typically urine)
Chain of custody (ensuring the sample is handled properly and cannot be tampered with)
Testing of samples (using approved laboratories)
Review of results by a Medical Review Officer (MRO) to ensure accuracy and consider any legitimate medical explanations for positive results
Types of Tests:
Pre-Employment Testing - Before hiring for a Safety-Sensitive Position
Random Testing: Unpredictable, unannounced testing throughout the year.
Post-Accident Testing: After certain types of accidents.
Reasonable Suspicion Testing: If trained supervisors observe behaviors that suggest drug use.
Return-to-Duty and Follow-up Testing: For those who have previously tested positive or violated the rules.
Consequences: Those who test positive or refuse a test are immediately removed from safety-sensitive duties. They can't return to those duties until they complete a process that includes:
An evaluation by a substance abuse professional (SAP)
Any required treatment
A return-to-duty test with a negative result
Follow-up tests.